Skip to content
LinkedIn
Twitter
Facebook
GLOBAL
US
Search for:
Physicians
Patients
Billing
Publications
About
News
Contact
Order a Test
News & Press
News & Press
kari.sharp@gmail.com
2024-01-25T13:00:38-08:00
Press Releases
SkylineDx Announces Grant of European Patent and Advances in Melanoma Diagnosis and Treatment
Jan 9, 2024
Read More
SkylineDx Presents Pioneering Data at ASH 2023: SKY92 Risk Stratification in Multiple Myeloma Patients
Dec 8, 2023
Read More
SkylineDx Announces Commercial Collaboration with Tempus to Advance Patient Care with its Merlin™ Test
Dec 5, 2023
Read More
Multicenter US Study Reveals CP-GEP’s Profound Impact on Stratifying Melanoma Patients for Long-Term Survival
Nov 6, 2023
Read More
Real World Prospective Study shows clinical implementation of Merlin Assay (CP-GEP) in melanoma care
Oct 31, 2023
Read More
OPTIMUM trial demonstrates value of SKY92 in detecting high-risk myeloma and improving patient outcome
Sep 28, 2023
Read More
Independent study shows favorable long term prognosis for CP-GEP Low Risk melanoma patients
Mar 17, 2023
Read More
SkylineDx announces Medicare coverage for its predictive melanoma assay Merlin
™
Test
May 25, 2022
Read More
Page load link
Go to Top